Conneqt HealthCQTHF 37 PS Ratio is 66.67 as of Jun. 27, 2026, which is 1654% above its 10-year median of 3.80. GuruFocus rates CQTHF with a GF Score™ of 37/100 and a GF Value™ of $0.55. The stock has 8 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Conneqt Health ranks better than 56.72% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Conneqt Health's share price is $0.40.
Conneqt Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01. Hence, Conneqt Health's PS Ratio for today is 66.67.
Good Sign:
Conneqt Health Ltd stock PS Ratio (=2.2) is close to 1-year low of 2.2.
The historical rank and industry rank for Conneqt Health's PS Ratio or its related term are showing as below:
CQTHF'
s PS Ratio Range Over the Past 10 Years
Min: 0.74 Med: 3.8 Max: 25.27
Current: 2.44
During the past 13 years, Conneqt Health's highest PS Ratio was 25.27. The lowest was 0.74. And the median was 3.80.
CQTHF's PS Ratio is ranked better than 56.72% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.86
vs CQTHF: 2.44
Conneqt Health Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Conneqt Health was -10.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -34.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -16.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -24.30% per year.
During the past 13 years, Conneqt Health's highest 3-Year average Revenue per Share Growth Rate was 41.90% per year. The lowest was -39.00% per year. And the median was -15.70% per year.
Back to Basics: PS Ratio
Conneqt Health (OTCPK:CQTHF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Conneqt Health PS Ratio Related Terms
Conneqt Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Conneqt Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Conneqt Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conneqt Health PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conneqt Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Conneqt Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Conneqt Health's Share Price of today is $0.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Conneqt Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Conneqt Health (CQTHF) has a PS Ratio of 66.67 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Conneqt Health and its competitors. This is 1654% above median its historical median of 3.80. Over the past decade, Conneqt Health's PS Ratio has ranged from 0.74 to 25.27. According to the industry distribution chart, Conneqt Health ranks #348 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 43.3%.
Is Conneqt Health's PS Ratio too high?
Conneqt Health's current PS Ratio of 66.67 is 1654% above median its 10-year median of 3.80. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 25.27. The Medical Devices & Instruments industry median PS Ratio is 2.86. Conneqt Health's value of 66.67 is 2231.1% above this industry median. Based on the distribution chart, Conneqt Health ranks #348 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Conneqt Health has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Conneqt Health's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Conneqt Health ranks #348 out of 804 companies for PS Ratio. This puts Conneqt Health in the upper half of its industry. The industry median PS Ratio is 2.86. Conneqt Health's value of 66.67 is 2231.1% above this benchmark. Historically, Conneqt Health's own PS Ratio has ranged from 0.74 to 25.27 over the past decade. While the company's 10-year median is 3.80 vs. the industry median of 2.86, Conneqt Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Conneqt Health's current PS Ratio of 66.67 is 2231.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Conneqt Health and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conneqt Health's current PS Ratio is 66.67, which is 1654% above median its own 10-year median of 3.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conneqt Health stock overvalued right now?
Conneqt Health (CQTHF) has a current PS Ratio of 66.67. The stock's GF Value™ is $0.55, compared to a current price of $0.40 — trading 27.3% below its estimated fair value. The current PS Ratio is 66.67, which is 1654% above median its 10-year median of 3.80 and 2231.1% above the Medical Devices & Instruments industry median of 2.86. Conneqt Health's overall GF Score™ is 37/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Conneqt Health (CQTHF), the current PS Ratio is 66.67 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Conneqt Health (CQTHF) Overvalued in 2026?
Based on GuruFocus' analysis, Conneqt Health stock appears to be undervalued.
The current stock price of $0.40 is trading 27.3% below its estimated GF Value™ of $0.55.
Key valuation signals for CQTHF:
PS Ratio: 66.67 (1654% above median its 10-year median of 3.80)
GF Value™: $0.55 vs. price of $0.40 (27.3% below fair value)
Industry Position: 2231.1% above the Medical Devices & Instruments median (#348 of 804)
No single metric tells the full story. See the CQTHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Conneqt Health Ltd is a health technology company, developing solutions for health disorders. The company designs medical devices for use in cardiovascular health management. The company is mainly engaged in manufacturing biomarkers that helps to detect associated risks, optimize heart health, and empower good cardiovascular decisions.
37GF Score
Get the complete analysis for CQTHF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CQTHF has been successfully added to your 
